TRDA
Price
$8.02
Change
-$0.78 (-8.86%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
300.76M
34 days until earnings call
TSHA
Price
$1.27
Change
-$0.05 (-3.79%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
260.35M
33 days until earnings call
Ad is loading...

TRDA vs TSHA

Header iconTRDA vs TSHA Comparison
Open Charts TRDA vs TSHABanner chart's image
Entrada Therapeutics
Price$8.02
Change-$0.78 (-8.86%)
Volume$6.17K
Capitalization300.76M
Taysha Gene Therapies
Price$1.27
Change-$0.05 (-3.79%)
Volume$28.04K
Capitalization260.35M
TRDA vs TSHA Comparison Chart
Loading...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TRDA vs. TSHA commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TRDA is a Hold and TSHA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (TRDA: $8.80 vs. TSHA: $1.32)
Brand notoriety: TRDA and TSHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TRDA: 148% vs. TSHA: 75%
Market capitalization -- TRDA: $300.76M vs. TSHA: $260.35M
TRDA [@Biotechnology] is valued at $300.76M. TSHA’s [@Biotechnology] market capitalization is $260.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TRDA’s FA Score shows that 0 FA rating(s) are green whileTSHA’s FA Score has 0 green FA rating(s).

  • TRDA’s FA Score: 0 green, 5 red.
  • TSHA’s FA Score: 0 green, 5 red.
According to our system of comparison, TRDA is a better buy in the long-term than TSHA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TRDA’s TA Score shows that 4 TA indicator(s) are bullish while TSHA’s TA Score has 5 bullish TA indicator(s).

  • TRDA’s TA Score: 4 bullish, 4 bearish.
  • TSHA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both TRDA and TSHA are a good buy in the short-term.

Price Growth

TRDA (@Biotechnology) experienced а -11.11% price change this week, while TSHA (@Biotechnology) price change was -26.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.57%. For the same industry, the average monthly price growth was -10.69%, and the average quarterly price growth was -14.76%.

Reported Earning Dates

TRDA is expected to report earnings on May 08, 2025.

TSHA is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-8.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRDA($301M) has a higher market cap than TSHA($260M). TRDA has higher P/E ratio than TSHA: TRDA (4.76) vs TSHA (2.70). TSHA YTD gains are higher at: -26.590 vs. TRDA (-53.730). TRDA has higher annual earnings (EBITDA): 50.8M vs. TSHA (-87.95M). TRDA has more cash in the bank: 420M vs. TSHA (139M). TRDA has less debt than TSHA: TRDA (59.2M) vs TSHA (63.2M). TRDA has higher revenues than TSHA: TRDA (211M) vs TSHA (8.33M).
TRDATSHATRDA / TSHA
Capitalization301M260M116%
EBITDA50.8M-87.95M-58%
Gain YTD-53.730-26.590202%
P/E Ratio4.762.70176%
Revenue211M8.33M2,532%
Total Cash420M139M302%
Total Debt59.2M63.2M94%
TECHNICAL ANALYSIS
Technical Analysis
TRDATSHA
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 11 days ago
86%
Bullish Trend 7 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Ad is loading...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PMGJX7.01N/A
N/A
Principal MidCap Growth J
MSQLX10.40N/A
N/A
Morgan Stanley Inst International Eq L
HNRGX29.07N/A
N/A
Hennessy Energy Transition Investor
WWNPX157.18N/A
N/A
Kinetics Paradigm No Load
JEMWX31.63N/A
N/A
JPMorgan Emerging Markets Equity R6

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been loosely correlated with CRNX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if TRDA jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
-9.09%
CRNX - TRDA
49%
Loosely correlated
-8.03%
RXRX - TRDA
49%
Loosely correlated
-9.26%
ATXS - TRDA
48%
Loosely correlated
-6.61%
IMNM - TRDA
45%
Loosely correlated
-7.00%
ARCT - TRDA
45%
Loosely correlated
-7.01%
More

TSHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TSHA has been loosely correlated with LOGC. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if TSHA jumps, then LOGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSHA
1D Price
Change %
TSHA100%
-3.79%
LOGC - TSHA
45%
Loosely correlated
-3.64%
ARWR - TSHA
35%
Loosely correlated
-4.96%
TRDA - TSHA
35%
Loosely correlated
-9.09%
ORMP - TSHA
35%
Loosely correlated
-2.27%
VYGR - TSHA
35%
Loosely correlated
-8.65%
More